Patent details

EP2139494 Title: PHARMACEUTICAL FORMULATIONS CONTAINING DAPAGLIFLOZIN PROPYLENE GLYCOL HYDRATE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2139494
WO Application Number:
US2008057888
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP08732695.5
WO Publication Number:
WO2008116179
EPO Publication Language:
English
SPC Number:
301054
First Applicant Residence Country:
Sweden (SE)
Publications:

Dates

Filing date:
21/03/2008
Grant date:
11/03/2020
EP Publication Date:
06/01/2010
WO Publication Date:
25/09/2008
Claims Translations Received Date:
Claims Translation B1 Received Date:
15/05/2020
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
11/03/2020
EP B1 Publication Date:
11/03/2020
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
20/03/2028
Lapsed By Expiration Date:
Patent Validated Date:
27/05/2020
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
11/03/2020
 
 

 

Name:
AstraZeneca AB
Address:
-, 151 85 SÖDERTÄLJE, Sweden (SE)

Agent

Name:
ir. W.J.J.M. Kempes
From:
26/05/2020
Address:
Dogio Patents Postbus 2350, 1200 CJ, Hilversum, Netherlands (NL)
To:

Inventor

1

Name:
BINDRA, Dilbir, S.
Address:
New Brunswick, NJ 08903, United States of America (US)

2

Name:
DALI, Mandar, V.
Address:
New Brunswick, NJ 08903, United States of America (US)

3

Name:
PARAB, Prakash, V.
Address:
New Brunswick, NJ 08903, United States of America (US)

4

Name:
PATEL, Jatin, M.
Address:
New Brunswick, NJ 08903, United States of America (US)

5

Name:
TAO, Li
Address:
New Brunswick, NJ 08903, United States of America (US)

6

Name:
TEJWANI, Ravindra, W.
Address:
New Brunswick, NJ 08903, United States of America (US)

7

Name:
VATSARAJ, Nipa
Address:
New Brunswick, NJ 08903, United States of America (US)

8

Name:
WU, Yongmei
Address:
New Brunswick, NJ 08903, United States of America (US)

Priority

Priority Patent Number:
896286 P
Priority Date:
22/03/2007
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 9/16; A61K 9/20; A61K 31/70; A61P 3/10;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
22/20
Publication date:
27/05/2020
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
11/20
Publication date:
11/03/2020
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
202011
Publication date:
11/03/2020
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
31/03/2026
Annual Fee Number:
19
Annual Fee Amount:
1300 Euro
Last Annual Payment Date:
19/02/2025
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
1200 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
26/05/2020 Outgoing Correspondence Letter no formal defects 1 PDF /2/3/3/5/2/0800525332/docs/ep08732695.5_0_345906l271.pdf
15/05/2020 Claims First filed claims 5 PDF /2/3/3/5/2/0800525332/docs/ep08732695.5_1_claims20200515154509673.pdf